Lenalidomide Maintenance Treatment in Patients With Primary Central Nervous System Lymphoma
Clinical trial NCT05260619 · RECRUITING
Trial details
- NCT number
- NCT05260619
- Sponsor
- Seoul National University Bundang Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-01
- Primary completion
- 2027-04-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.